Peritoneal Fluid Analysis

How to Cite This Chapter: Juszczyk J, Jaroszewicz J. Peritoneal Fluid Analysis. McMaster Textbook of Internal Medicine. Kraków: Medycyna Praktyczna. https://empendium.com/mcmtextbook/chapter/B31.1269.3.205.6. Accessed May 26, 2024.
Last Updated: February 4, 2022
Last Reviewed: February 4, 2022
Chapter Information

Table 1

Table 20.4-1. Peritoneal fluid analysis

Analyte

Result and interpretation

ADA

≥40 IU/L

Suggestive of tuberculosis

Albumin, [S] – [P]

≥11 g/L

Portal hypertension, cirrhosis, alcoholic hepatitis, multiple metastases to the liver, heart failure

<11 g/L

Peritoneal metastases, tuberculosis, pancreatitis, serositis, nephrotic syndrome

Protein, total

<10 g/L

Increased risk of spontaneous bacterial peritonitis in cirrhosis

≥10 g/L

Peritonitis secondary to esophageal perforation

Glucose, [P]/[S]

<1.0

WBCs, bacteria, and neoplastic cells in the fluid; glucose levels may be indeterminable in esophageal perforation

LDH, [P]/[S]

~0.4

Ascites without complications in cirrhosis

>1.0

Infection, malignancy

Amylase, [P]/[S]

>1.0

Pancreatic diseases, ~6.0 in esophageal perforation, ~0.4 in ascites without complications in cirrhosis

Bilirubin, [P]/[S]

>1.0

Bile duct perforation

Triglycerides

>2.26 mmol/L

(200 mg/dL)

Chyloperitoneum, often >11 mmol/L (1000 mg/dL)

ADA, adenosine deaminase; [P]/[S], concentration in the peritoneal fluid divided by serum concentration; [S] – [P], serum concentration minus concentration in the peritoneal fluid; WBC, white blood cell.

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.